1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Substance Use Block Grant (SUBG): Trauma-Informed Substance Use Prevention Program (TISUPP) is sponsored by Arizona Governor's Office of Youth, Faith and Family (GOYFF). This program provides funding to organizations for the development and implementation of evidence-based drug prevention programs, including screening and assessment of behavioral health and substance abuse, opportunities for increased engagement of healthy youth, and drug education for adults and families.
Get alerted about grants like this
Save a search for “Arizona Governor's Office of Youth, Faith and Family (GOYFF)” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
$4 Million Available to Prevent Substance Use and Misuse Across Arizona | Governor's Office of Youth, Faith and Family Governor's Office of Youth, Faith and Family $4 Million Available to Prevent Substance Use and Misuse Across Arizona PHOENIX — Today, the Governor’s Office of Youth, Faith and Family (GOYFF) announced it is now accepting applications for the Trauma-Informed Substance Use Prevention Program (TISUPP) Grant (RFGA#: RFGA-SUBG-GOYFF-100126-01).
Approximately $4 million will be awarded to programs throughout Arizona to strengthen community-based primary prevention efforts that address the root causes of substance use before it starts. Funding will support strategies that promote and improve healthy outcomes for Arizonans with a focus on families and youth at higher risk for substance use.
Applicants may apply under one of two tracks aligned with statewide needs assessments: Community Connection & Positive Development Track: Builds supportive community and family environments. Youth in Schools Track: Focuses on youth knowledge and attitudes within school-based settings. The maximum annual grant award is $200,000 per recipient and is renewable for a combined term of three years.
Eligible applicants include Arizona-based organizations with a minimum of two years of experience providing primary prevention services.
Eligible entities include 501(c)(3) non-profit organizations; Substance Use Prevention Coalitions; Tribal Nations, Tribal Coalitions, and Tribal Communities; Local Education Agencies (LEAs) (traditional Public School Districts, County Offices of Education, and Direct-Funded Charter Schools); city, county, or state government agencies; and faith-based organizations.
The grant application window will close at 11:59 PM (Arizona time) on June 15, 2026. Applicants must create a free Euna Grants (previously eCivis) account to access the complete grant solicitation and submit their application. An optional pre-application conference will be held via Zoom on Friday, May 15, 2026, at 1:00 PM (Arizona time).
Register through Zoom to receive additional details about the pre-application conference. For additional assistance regarding this opportunity, please contact Procurement Manager Shane Richardson at [email protected] . The monies awarded under this request for grant application (RFGA) are federal funds distributed from the Substance Use Prevention, Treatment, and Recovery Services Block Grant (SUPTRS BG, or SUBG for short) program.
Established by Congress in 1981, and administered by the Substance Abuse and Mental Health Services Administration (SAMHSA)’s Center for Substance Abuse Prevention (CSAP) and Center for Substance Abuse Treatment (CSAT), the SUBG is the largest federal funding source dedicated to the prevention and treatment of substance use disorders.
In Arizona, the Arizona Health Care Cost Containment System (AHCCCS) receives SUBG funds and allocates a portion to the GOYFF to administer the TISUPP Grant. Awards are subject to applicable federal regulations ( Uniform Guidance (2 C. F.
R Part 200) ) and state statutes ( A. R. S.
§41-2701 et al ). Apply for the TISUPP Grant!
Arizona Recognizes April 2026 as Alcohol Awareness Month Arizona Recognizes April 2026 as Sexual Assault Awareness Month Applications Open for 2026-2027 Governor’s Youth Commission $100K Available to Prevent Child Abuse & Neglect in Arizona Governor's Advisory Council on Aging Arizona Parents Commission on Drug Education & Prevention Governor’s Commission to Prevent Intimate Partner and Gender-Based Violence Governor's Commission on Service and Volunteerism Governor's Advisory Council on Aging Smart & Simple Steps to Take Charge of Your Health Care | Medical Advocacy for Older Adults
Based on current listing details, eligibility includes: Public and private organizations that address priority issues related to substance use prevention. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Unspecified Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is June 15, 2026. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
Past winners and funding trends for this program
Substance Use Block Grant (SUBG): Trauma-Informed Substance Use Prevention Program (TISUPP) is sponsored by Arizona Governor's Office of Youth, Faith and Family (GOYFF) via Arizona Health Care Cost Containment System (AHCCCS). This program develops and implements evidence-based drug prevention programs that provide screening and assessment of behavioral health and substance abuse, opportunities for increased engagement of healthy youth, and drug education for adults and families.
Parents Commission Grant is a grant from the Arizona Governor's Office of Youth, Faith and Family (GOYFF) that funds programs that increase parental involvement and educate communities about the serious health risks associated with alcohol and controlled substance abuse. Established through a 1996 voter initiative, the Arizona Parents Commission on Drug Education and Prevention distributes funds from the Drug Treatment and Education Fund through a competitive grant application process. In State Fiscal Year 2026, $4.76 million was awarded to programs throughout Arizona, with grantees including youth partnerships, behavioral health services, school districts, and advocacy centers. Eligible applicants include nonprofit organizations and community programs operating substance-use prevention and parental education initiatives across Arizona.
Children's Justice Act (CJA) is sponsored by Arizona Governor's Office of Youth, Faith and Family (GOYFF). This grant program provides funding to states to improve the investigation, prosecution, and judicial handling of cases of child abuse and neglect, particularly child sexual abuse and exploitation, in a manner that limits additional trauma to the child victim.
-Purpose. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop, standardize, and validate new and innovative assays, integrated strategies, or batteries of assays that determine or predict specific organ toxicities (e.g., ocular, dermal, hematotoxicity, cardiotoxicity, gastrointestinal toxicity, hepatotoxicity, nephrotoxicity, ototoxicity, olfactory loss, bladder toxicity, neurotoxicity, pulmonary toxicity, endocrine toxicity, and pancreatic beta cell toxicity), resulting from both acute and chronic exposures to various chemicals, environmental pollutants, biologics and therapeutic molecules or drugs. In addition, this FOA encourages the development, standardization, and validation of new models of arthritis, convulsion, infection and shock. New approaches for high throughput toxicity screening that involves the use of molecular endpoints, computer modeling, proteomics, genomics and epigenomics and the development of virtual tissues are also encouraged as are development of 3-dimensional organ models for toxicity evaluation. -Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-09-007, which encourages applications under the Small Business Technology Transfer (STTR) (R41/R42) grant mechanisms. Funding Opportunity Number: PA-09-006. Assistance Listing: 93.113,93.173,93.361,93.389,93.837,93.846,93.847,93.848,93.849,93.859,93.867. Funding Instrument: G. Category: ED,ENV,FN,HL.
Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), invites Small Business Innovation Research (SBIR) cooperative agreement applications from small business concerns (SBCs) that propose to develop new, or to improve existing application(s) of nanotechnology-based therapeutics or/and in vivo diagnostics. This FOA will specifically support pre-clinical optimization and testing of these cancer-relevant nanotechnology applications against the intended cancer type. The proposed projects must be milestone-driven and must be clearly directed toward development of an ultimate commercial product. The outcomes are expected to advance the discovery and pre-clinical optimization phase so that an Investigational New Drug (IND) or Investigational Device Exemptions (IDE) application could be submitted to the Food and Drug Administration (FDA) by the end or shortly after completion of the Phase II project period. To facilitate these steps, the NCI will assist the awardees in various ways, including the support through the NCI-sponsored Nanotechnology Characterization Laboratory. This FOA will NOT support basic research projects, studies on disease mechanisms, and clinical trials. Mechanism of Support. This FOA will utilize the SBIR (U43/U44) cooperative agreement mechanisms for Phase I and Phase II applications. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. Funding Opportunity Number: PAR-10-286. Assistance Listing: 93.393,93.394,93.395,93.396. Funding Instrument: CA. Category: ED,HL. Award Amount: Up to $150K per award.